Baker Bros. Advisors’s First Tracks Biotherapeutics TRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding TRAX
Baker Bros. Advisors's TRAX Position: Q3 2026 in Review
Baker Bros. Advisors opened a new position in First Tracks Biotherapeutics (TRAX) in Q3 2026: 472,932 shares worth $16.8M. The stake represents 0.08% of the portfolio and ranks #52 among its holdings.
182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.
- Baker Bros. Advisors held 472,932 shares of First Tracks Biotherapeutics worth $16.8M as of Q3 2026.
- First Tracks Biotherapeutics was a new Baker Bros. Advisors position in Q3 2026.
- First Tracks Biotherapeutics made up 0.08% of Baker Bros. Advisors's portfolio in Q3 2026, its #52 holding.
- 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.
Based on Baker Bros. Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.